SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001193125-24-073818
Filing Date
2024-03-21
Accepted
2024-03-21 16:00:56
Documents
1
Effectiveness Date
2024-03-21

Document Format Files

Seq Description Document Type Size
1 15-12G d798525d1512g.htm 15-12G 10668
  Complete submission text file 0001193125-24-073818.txt   11758
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-38800 | Film No.: 24771211
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)